Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | United States | $17.21M | 64,464,412 | 35.53% | 64.47% | Net Buying | Net Buying |
| INTZ | INTRUSION INC | United States | $3.13M | 1,944,675 | 8.92% | 91.08% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.67M | 466,761,105 | 0.75% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $10.42M | 198,386,080 | 1.23% | 0.00% | ||
| IQ | IQIYI INC | China | $4.70B | 6,716,137,085 | 4.53% | 0.00% | ||
| GOEV | CANOO INC | United States | $164.86M | 64,397,326 | 44.63% | 55.37% | Net Buying | |
| CLNN | CLENE INC | United States | $49.70M | 128,433,721 | 9.06% | 52.66% | Net Buying | Net Selling |
| LIFE | ATYR PHARMA INC | United States | $116.63M | 69,010,940 | 59.74% | 22.13% | Net Buying | |
| BPTH | BIO-PATH HOLDINGS INC | United States | $1.85M | 678,795 | 3.24% | 96.76% | ||
| KZR | KEZAR LIFE SCIENCES INC | United States | $56.28M | 72,801,359 | 67.83% | 21.82% | Net Buying | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $8.39M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| BIOL | BIOLASE INC | United States | $5.50M | 32,522,593 | 0.92% | 56.96% | ||
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $55.28M | 36,850,279 | 13.26% | 7.77% | Net Selling | Net Selling |
| LYRA | LYRA THERAPEUTICS INC | United States | $22.68M | 60,964,859 | 69.46% | 14.19% | Net Buying | |
| OCUP | OCUPHIRE PHARMA INC | United States | $44.59M | 25,924,158 | 1.23% | 98.77% | Net Buying | Net Buying |
| GOSS | GOSSAMER BIO INC | United States | $167.85M | 226,218,652 | 86.47% | 13.53% | Net Buying | Net Selling |
| AADI | AADI BIOSCIENCE INC | United States | $43.71M | 24,554,205 | 26.93% | 73.07% | Net Selling | Net Selling |
| APLM | APOLLOMICS INC | United States | $33.29M | 89,495,790 | 9.89% | 0.00% | ||
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.33M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $29.85M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.22M | 3,069,516 | 1.86% | 98.14% | Net Buying | |
| MVST | MICROVAST HOLDINGS INC | United States | $135.13M | 317,196,095 | 20.63% | 31.20% | Net Selling | |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $52.21M | 27,918,560 | 18.78% | 38.25% | ||
| FEMY | FEMASYS INC | United States | $26.89M | 22,220,718 | 6.38% | 8.01% | ||
| IMRX | IMMUNEERING CORP | United States | $43.00M | 29,653,355 | 53.75% | 46.25% | Net Selling | Net Selling |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $15.47M | 53,156,369 | 22.27% | 77.73% | Net Selling | |
| YTEN | YIELD10 BIOSCIENCE INC | United States | $3.88M | 641,738 | 2.09% | 97.91% | Net Buying | Net Buying |
| TARA | PROTARA THERAPEUTICS INC | United States | $61.77M | 20,589,976 | 12.01% | 87.99% | Net Selling | Net Selling |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $90.35M | 53,149,778 | 33.44% | 24.16% | ||
| INAB | IN8BIO INC | United States | $44.57M | 44,123,949 | 19.45% | 51.06% | Net Buying | |
| SYBX | SYNLOGIC INC | United States | $20.85M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $103.40M | 26,996,740 | 21.43% | 5.19% | Net Selling | Net Selling |
| GEVO | GEVO INC | United States | $169.14M | 236,232,717 | 35.74% | 11.14% | Net Selling | |
| VOR | VOR BIOPHARMA INC | United States | $116.72M | 68,259,602 | 87.32% | 10.15% | Net Selling | Net Selling |
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $73.06M | 54,933,774 | 81.93% | 18.07% | Net Buying | Net Buying |
| PRST | PRESTO AUTOMATION INC | United States | $13.41M | 80,791,967 | 8.56% | 68.69% | Net Buying | |
| PGEN | PRECIGEN INC | United States | $316.13M | 248,919,096 | 25.15% | 73.45% | Net Buying | Net Selling |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $146.92M | 202,645,716 | 46.82% | 14.34% | Net Selling | Net Buying |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $11.93M | 284,379,960 | 0.99% | 5.95% | ||
| ACET | ADICET BIO INC | United States | $120.77M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $72.21M | 22,217,265 | 4.15% | 95.85% | ||
| GRTS | GRITSTONE BIO INC | United States | $85.12M | 108,569,374 | 38.76% | 20.10% | Net Buying | |
| CVKD | CADRENAL THERAPEUTICS INC | United States | $7.36M | 16,008,469 | 3.45% | 46.72% | Net Buying | |
| LUMO | LUMOS PHARMA INC | United States | $23.51M | 8,107,121 | 17.70% | 82.30% | Net Buying | Net Buying |
| FBIO | FORTRESS BIOTECH INC | United States | $32.12M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $141.70M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| IKNA | IKENA ONCOLOGY INC | United States | $62.25M | 48,258,111 | 66.60% | 18.22% | ||
| MBRX | MOLECULIN BIOTECH INC | United States | $11.00M | 2,311,536 | 45.78% | 54.22% | Net Buying | |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $98.64M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $537.47M | 68,380,857 | 33.60% | 50.20% | Net Selling | Net Selling |
| AGEN | AGENUS INC | United States | $220.28M | 20,999,261 | 63.15% | 36.85% | Net Buying | Net Buying |
| AQMS | AQUA METALS INC | United States | $50.49M | 111,953,875 | 17.59% | 15.42% | Net Selling | |
| IVA | INVENTIVA SA | France | $176.15M | 52,115,807 | 9.33% | 0.00% | ||
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.21% | 0.00% | ||
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $99.04M | 32,260,510 | 26.67% | 12.70% | ||
| HOOK | HOOKIPA PHARMA INC | United States | $75.99M | 98,950,107 | 35.22% | 26.83% | Net Buying | |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $34.28M | 41,149,160 | 63.59% | 36.41% | Net Selling | Net Selling |
| PASG | PASSAGE BIO INC | United States | $81.73M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
| CARA | CARA THERAPEUTICS INC | United States | $39.13M | 54,656,413 | 44.64% | 53.41% | Net Selling | Net Selling |
| NTBL | NOTABLE LABS LTD | Israel | $11.27M | 9,018,261 | 2.49% | 97.51% | Net Selling | |
| AMLX | AMYLYX PHARMACEUTICALS INC | United States | $119.35M | 68,005,749 | 52.42% | 47.58% | Net Buying | Net Selling |
| SGMO | SANGAMO THERAPEUTICS INC | United States | $116.41M | 207,510,076 | 41.89% | 15.51% | Net Selling | Net Selling |
| CRBU | CARIBOU BIOSCIENCES INC | United States | $319.72M | 90,317,771 | 76.47% | 8.74% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.